Stayble Therapeutics AB

At a glance

Most recent filing on December 6, 2024 — an open-market purchase by Andreas Gerward on Dec 6, 2024.

We hold 18 visible filings, going back to March 6, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 18 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 18. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Andreas Gerward Chief executive officer
18,800 SEKOpen-market buy
TradedDec 6, 2024FiledDec 6, 2024
Fullriggaren Konsult Aktiebolag Closely associated: Chief financial officer
10,240 SEKOpen-market buy
TradedJun 12, 2024FiledJun 12, 2024
Andreas Gerward Chief executive officer
48,000 SEKOpen-market buy
TradedJun 12, 2024FiledJun 12, 2024
Fullriggaren Konsult Aktiebolag Closely associated: Chief financial officer
13,900 SEKOpen-market buy
TradedDec 8, 2023FiledDec 8, 2023
Elisabeth Pålsson Closely associated: Chief financial officer
9,600 SEKOpen-market buy
TradedJul 14, 2023FiledJul 15, 2023